Marvai LifeSciences has acquired assets and intellectual property from Molecular Assemblies at undisclosed terms. Marvai, a San Diego company, said Tuesday that the acquisition would expand the ...
CRISPR-Cas systems are prokaryotic immune systems that confer resistance to foreign genetic elements such as plasmids and phages. CRISPR-Cas systems have been exploited for targeted genome editing ...
Kennedy says he plans to divest as much as $50,000 with Dragonfly Therapeutics, a pharmaceutical company that develops cancer drugs, as well as up to $15,000 he has in CRISPR Therapeutics, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback